Download App

Log in to access Online Inquiry
Company Overview More
Hangzhou Qiming Medical Devices Co., Ltd. is a Chinese company engaged in the development, manufacture and sale of minimally invasive medical devices and auxiliary devices for the treatment of cardiac valvular diseases. The company's main products include VenusA-Valve system, VenusA-Plus system, VenusA-Pilot system, VenusP-Valve system, TMVR valve, TTVR valve, valvuloplasty balloon V8/TAV8 and TriGUARD3 cerebral embolism protection equipment.
CEO: Min Ceng
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

02500 Venus Medtech (Hangzhou) Inc.
12.360+0.440+3.69%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Assets
Current assets
Inventory
51.11% 90.52M 74.94% 66.25M 141.66% 59.9M -- 37.87M
Accounts receivable
30.76% 302.1M 113.05% 341.88M 42.44% 231.03M -- 160.47M
Related party payments receivable
-- -- -- -- -- 22.5M -- --
Advance deposits and other receivables
155.07% 89.23M -43.01% 63.86M -88.47% 34.98M -- 112.06M
Cash and equivalents
9.12% 2.96B 81.76% 3.58B 12.22% 2.71B -- 1.97B
Secured deposit
-99.01% 2.56M -9.2% 252.76M 34714.48% 259.72M -- 278.36M
Financial assets at fair value-current assets
-- -- -- -- -- 44.13M -- --
Total current assets
2.36% 3.44B 68.26% 4.3B 15.7% 3.36B -- 2.56B
Non-current assets
Property, plant and equipment
105.26% 142.24M 58.2% 105.6M 14.76% 69.3M -- 66.75M
Advance payment
-38.03% 16.93M -- -- -- 27.32M -- --
Associated company interest
100.51% 76.18M 1109.57% 82.41M -- 38M -- 6.81M
Stock investment
148.18% 16.19M -- -- -- 6.53M -- --
Financial assets at fair value-non-current assets
640.08% 477.16M 408.92% 144.58M -- 64.47M -- 28.41M
Other investments
-- -- -- -- -- -- -- 30.18M
Intangible assets
30.79% 304.74M 14.93% 227.97M 25.85% 233M -- 198.36M
Goodwill
6.65% 519.74M -7.98% 482.5M 1.6% 487.32M -- 524.36M
Deferred tax assets
606.75% 8.17M -90.18% 297K -58.71% 1.16M -- 3.03M
Special items of non-current assets
253.34% 108.51M -31.58% 46.5M -15.64% 30.71M -- 67.96M
Adjustment items of non-current assets
-- -33K -- -- -- -- -- --
Total non-current assets
74.34% 1.67B 17.71% 1.09B 25.31% 957.79M -- 925.86M
Total assets
18.32% 5.11B 54.83% 5.39B 17.7% 4.32B -- 3.48B
Liabilities
Current liabilities
Accounts payable
65.27% 8.75M 92.71% 7.71M 264.67% 5.3M -- 4M
Tax payable
-- 480K -- -- -- -- -- 2.2M
Amounts payable to associated parties-current liabilities
-- -- -- -- -- -- -- 685K
Other payables and accrued expenses
-59.63% 144.73M 0.29% 361.62M -9.61% 358.49M -- 360.56M
Bank loans and overdrafts
-- 4.9M -- -- -- -- -- --
Financial lease liabilities-current liabilities
59.82% 17.73M 42.52% 13.76M 23.35% 11.09M -- 9.66M
Other current liabilities
-0.35% 14.11M 79.08% 21.23M 14.5% 14.16M -- 11.86M
Special items of current liabilities
8.19% 17.84M -33.09% 17.75M -37.64% 16.49M -- 26.53M
Total current liabilities
-48.58% 208.53M 1.59% 422.08M -28.66% 405.52M -- 415.49M
Net current assets
9.35% 3.23B 81.19% 3.88B 26.5% 2.95B -- 2.14B
Total assets less current liabilities
25.26% 4.9B 62.04% 4.97B 26.2% 3.91B -- 3.07B
Non-current liabilities
Other loans-non-current liabilities
-- -- -- -- -- -- -- 981K
Long-term accounts payable
-- 167.48M -- -- -- -- -- --
Financial lease liabilities-non-current liabilities
122.18% 48.15M 4.2% 18.05M 25.18% 21.67M -- 17.33M
Deferred tax liability
62.26% 53.45M -20.99% 31.66M -11.66% 32.94M -- 40.06M
Special items of non-current liabilities
-- -- -- -- -- 1.06M -- --
Total non-current liabilities
383.3% 269.08M -14.84% 49.71M 1.96% 55.68M -- 58.37M
Total liabilities
3.56% 477.61M -0.44% 471.79M -25.98% 461.19M -- 473.86M
Total assets less total liabilities
20.09% 4.63B 63.53% 4.92B 26.64% 3.86B -- 3.01B
Total equity and non-current liabilities
25.26% 4.9B 62.04% 4.97B 26.2% 3.91B -- 3.07B
Equity
Share capital
4.27% 441.01M 9.03% 441.01M 4.57% 422.97M -- 404.47M
Reserve
20.99% 4.1B 71.12% 4.44B 28.87% 3.39B -- 2.6B
Legal reserve
20.99% 4.1B 71.12% 4.44B 28.87% 3.39B -- 2.6B
Shareholders' Equity
19.14% 4.55B 62.76% 4.89B 25.63% 3.82B -- 3B
Non-controlling interest
107.19% 86.21M 327.91% 37.46M 374.58% 41.61M -- 8.75M
Total equity
20.09% 4.63B 63.53% 4.92B 26.64% 3.86B -- 3.01B
Total equity and total liabilities
18.32% 5.11B 54.83% 5.39B 17.7% 4.32B -- 3.48B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
Ernst & Young accounting firm--Ernst & Young accounting firm--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%